CA2629402A1 - Modulateurs de beta-secretase et procedes d'utilisation associes - Google Patents

Modulateurs de beta-secretase et procedes d'utilisation associes Download PDF

Info

Publication number: CA2629402A1
Authority: CA; Canada
Prior art keywords: amino; acetamide; methyl; dihydrospiro; pyridin
Prior art date: 2005-11-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002629402A

Other languages

English (en)

Other versions

CA2629402C (fr

Inventor

Wenge Zhong

Stephen Hitchcock

Brian K Albrecht

Michael Bartberger

James Brown

Ryan Brown (Deceased)

Stuart C. Chaffee

Yuan Cheng

Michael Croghan

Russell Graceffa

Scott Harried

Dean Hickman

Daniel Horne

Randall Hungate

Ted Judd

Matthew Kaller

Charles Kreiman

Daniel La

Patricia Lopez

Craig E. Masse

Holger Monenschein

Thomas Nguyen

Thomas Nixey

Vinod F. Patel

Lewis Pennington

Matthew Weiss

Qiufen Xue

Bryant Yang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Amgen Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-21

Filing date

2006-11-13

Publication date

2007-05-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39708735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2629402(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-11-13 Application filed by Individual filed Critical Individual

2007-05-31 Publication of CA2629402A1 publication Critical patent/CA2629402A1/fr

2011-07-26 Application granted granted Critical

2011-07-26 Publication of CA2629402C publication Critical patent/CA2629402C/fr

Status Expired - Fee Related legal-status Critical Current

2026-11-13 Anticipated expiration legal-status Critical

Links

102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title claims abstract 5
108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title claims abstract 5
238000000034 method Methods 0.000 title abstract 3
150000001875 compounds Chemical class 0.000 claims abstract 33
208000024827 Alzheimer disease Diseases 0.000 claims abstract 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 4
239000008194 pharmaceutical composition Substances 0.000 claims abstract 4
230000000694 effects Effects 0.000 claims abstract 3
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 732
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 270
-1 C2-10-alkynyl Chemical group 0.000 claims 164
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 146
125000005842 heteroatom Chemical group 0.000 claims 78
125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 57
125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 55
125000004122 cyclic group Chemical group 0.000 claims 50
229910020008 S(O) Inorganic materials 0.000 claims 48
125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 46
125000001188 haloalkyl group Chemical group 0.000 claims 45
125000001424 substituent group Chemical group 0.000 claims 44
125000002950 monocyclic group Chemical group 0.000 claims 40
229910052760 oxygen Inorganic materials 0.000 claims 39
125000002619 bicyclic group Chemical group 0.000 claims 37
125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 34
125000004432 carbon atom Chemical group C* 0.000 claims 31
125000005843 halogen group Chemical group 0.000 claims 30
125000004043 oxo group Chemical group O=* 0.000 claims 29
108091008648 NR7C Proteins 0.000 claims 28
125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 27
229910052757 nitrogen Inorganic materials 0.000 claims 27
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 27
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 26
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 25
229920006395 saturated elastomer Polymers 0.000 claims 25
125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 24
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 22
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 18
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 18
125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 17
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 17
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 17
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 17
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 17
GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims 17
JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims 16
MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims 16
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 16
QMYGFTJCQFEDST-UHFFFAOYSA-N 3-methoxybutyl acetate Chemical group COC(C)CCOC(C)=O QMYGFTJCQFEDST-UHFFFAOYSA-N 0.000 claims 15
125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 15
125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 14
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 14
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 14
229910052717 sulfur Inorganic materials 0.000 claims 14
125000000842 isoxazolyl group Chemical group 0.000 claims 11
239000003814 drug Substances 0.000 claims 10
125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 10
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 9
206010012289 Dementia Diseases 0.000 claims 8
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 8
125000002541 furyl group Chemical group 0.000 claims 8
125000002883 imidazolyl group Chemical group 0.000 claims 8
125000001786 isothiazolyl group Chemical group 0.000 claims 8
125000003971 isoxazolinyl group Chemical group 0.000 claims 8
125000002757 morpholinyl group Chemical group 0.000 claims 8
125000001715 oxadiazolyl group Chemical group 0.000 claims 8
125000005968 oxazolinyl group Chemical group 0.000 claims 8
125000002971 oxazolyl group Chemical group 0.000 claims 8
125000004193 piperazinyl group Chemical group 0.000 claims 8
125000003386 piperidinyl group Chemical group 0.000 claims 8
125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 claims 8
125000002755 pyrazolinyl group Chemical group 0.000 claims 8
125000003226 pyrazolyl group Chemical group 0.000 claims 8
125000004076 pyridyl group Chemical group 0.000 claims 8
125000000714 pyrimidinyl group Chemical group 0.000 claims 8
125000000719 pyrrolidinyl group Chemical group 0.000 claims 8
125000000168 pyrrolyl group Chemical group 0.000 claims 8
125000003718 tetrahydrofuranyl group Chemical group 0.000 claims 8
125000001113 thiadiazolyl group Chemical group 0.000 claims 8
125000002769 thiazolinyl group Chemical group 0.000 claims 8
125000000335 thiazolyl group Chemical group 0.000 claims 8
125000001544 thienyl group Chemical group 0.000 claims 8
125000004306 triazinyl group Chemical group 0.000 claims 8
125000001425 triazolyl group Chemical group 0.000 claims 8
125000000304 alkynyl group Chemical group 0.000 claims 7
125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 6
125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 6
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims 6
YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 6
KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 6
KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 6
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 6
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 6
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 6
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 6
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims 6
125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims 6
125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 6
125000004663 dialkyl amino group Chemical group 0.000 claims 6
125000001041 indolyl group Chemical group 0.000 claims 6
125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 6
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 6
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims 6
QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 5
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 5
125000003342 alkenyl group Chemical group 0.000 claims 4
125000002393 azetidinyl group Chemical group 0.000 claims 4
125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims 4
125000001624 naphthyl group Chemical group 0.000 claims 4
125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 claims 4
125000003373 pyrazinyl group Chemical group 0.000 claims 4
PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims 4
125000002098 pyridazinyl group Chemical group 0.000 claims 4
150000003839 salts Chemical class 0.000 claims 4
125000003831 tetrazolyl group Chemical group 0.000 claims 4
125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims 3
125000006725 C1-C10 alkenyl group Chemical group 0.000 claims 3
125000004399 C1-C4 alkenyl group Chemical group 0.000 claims 3
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 3
PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 3
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 3
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 3
FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 3
125000000217 alkyl group Chemical group 0.000 claims 3
239000003937 drug carrier Substances 0.000 claims 3
ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 claims 3
LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 claims 3
WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims 3
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 3
VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 claims 3
229930192474 thiophene Natural products 0.000 claims 3
150000003852 triazoles Chemical class 0.000 claims 3
125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 2
125000005871 1,3-benzodioxolyl group Chemical group 0.000 claims 2
KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims 2
208000005145 Cerebral amyloid angiopathy Diseases 0.000 claims 2
206010008111 Cerebral haemorrhage Diseases 0.000 claims 2
201000010374 Down Syndrome Diseases 0.000 claims 2
208000018737 Parkinson disease Diseases 0.000 claims 2
101100160255 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) YLR154C-H gene Proteins 0.000 claims 2
206010048327 Supranuclear palsy Diseases 0.000 claims 2
206010044688 Trisomy 21 Diseases 0.000 claims 2
DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 claims 2
206010002022 amyloidosis Diseases 0.000 claims 2
125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 claims 2
230000015572 biosynthetic process Effects 0.000 claims 2
210000004556 brain Anatomy 0.000 claims 2
208000010877 cognitive disease Diseases 0.000 claims 2
230000001054 cortical effect Effects 0.000 claims 2
230000007850 degeneration Effects 0.000 claims 2
230000003412 degenerative effect Effects 0.000 claims 2
208000035475 disorder Diseases 0.000 claims 2
229910052739 hydrogen Inorganic materials 0.000 claims 2
125000004857 imidazopyridinyl group Chemical group N1C(=NC2=C1C=CC=N2)* 0.000 claims 2
125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 2
210000004558 lewy body Anatomy 0.000 claims 2
208000027061 mild cognitive impairment Diseases 0.000 claims 2
239000000651 prodrug Substances 0.000 claims 2
229940002612 prodrug Drugs 0.000 claims 2
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 claims 2
239000012453 solvate Substances 0.000 claims 2
125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims 2
125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims 2
KIFUPYQGMFVLPJ-UGIQSDBZSA-N (3s)-n-[(2s,3r)-1-(3-cyanophenyl)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]-1-cyclobutyl-5-oxopyrrolidine-3-carboxamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(C=CC=2)C#N)NC(=O)[C@H]2CC(=O)N(C3CCC3)C2)C2)=CC(CC)=CC=C1OC12CCC1 KIFUPYQGMFVLPJ-UGIQSDBZSA-N 0.000 claims 1
125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 1
125000006728 (C1-C6) alkynyl group Chemical group 0.000 claims 1
VQGHMDXJFVFTGK-XZLNYOFQSA-N (e)-3-(4-bromofuran-2-yl)-n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]prop-2-enamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)\C=C\C=2OC=C(Br)C=2)C2)=CC(CC)=CC=C1OC12CCC1 VQGHMDXJFVFTGK-XZLNYOFQSA-N 0.000 claims 1
ZUTJTMUOWJGQBF-HZFUHODCSA-N 2-(1,3-benzothiazol-2-yloxy)-n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)COC=2SC3=CC=CC=C3N=2)C2)=CC(CC)=CC=C1OC12CCC1 ZUTJTMUOWJGQBF-HZFUHODCSA-N 0.000 claims 1
JRDCYXKZYKGTNK-YTCPBCGMSA-N 2-(3,5-dimethyl-1,2-oxazol-4-yl)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound CC1=NOC(C)=C1CC(=O)N[C@H]([C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)CC1=CC=CC=C1 JRDCYXKZYKGTNK-YTCPBCGMSA-N 0.000 claims 1
YGYAGJFOMUUTBI-YTCPBCGMSA-N 2-(3-chloro-2-methylphenyl)sulfanyl-n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)CSC=2C(=C(Cl)C=CC=2)C)C2)=CC(CC)=CC=C1OC12CCC1 YGYAGJFOMUUTBI-YTCPBCGMSA-N 0.000 claims 1
XDASZKNLEKIPAS-XQTSOSNCSA-N 3-(benzimidazol-1-yl)-n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-methylpropanamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)C(C)CN2C3=CC=CC=C3N=C2)C2)=CC(CC)=CC=C1OC12CCC1 XDASZKNLEKIPAS-XQTSOSNCSA-N 0.000 claims 1
125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 claims 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 1
PCBZRNYXXCIELG-WYFCWLEVSA-N COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 Chemical compound COC1=CC=C(C[C@H](NC(=O)OC2CCCC3(C2)OOC2(O3)C3CC4CC(C3)CC2C4)C(=O)N[C@@H]2[C@@H](CO)O[C@H]([C@@H]2O)N2C=NC3=C2N=CN=C3N(C)C)C=C1 PCBZRNYXXCIELG-WYFCWLEVSA-N 0.000 claims 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 claims 1
125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
125000003545 alkoxy group Chemical group 0.000 claims 1
125000000278 alkyl amino alkyl group Chemical group 0.000 claims 1
229910052799 carbon Inorganic materials 0.000 claims 1
125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 1
NOEBJLGZGKXWLU-DSITVLBTSA-N n-[(2r,3s)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-[3-fluoro-4-(trifluoromethyl)phenyl]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@@H](NC(=O)C)[C@@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C1=CC=C(C(F)(F)F)C(F)=C1 NOEBJLGZGKXWLU-DSITVLBTSA-N 0.000 claims 1
FOQIMCMQAHVRSZ-CCIHKAHMSA-N n-[(2s,3r)-1-(1-acetylpiperidin-3-yl)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC2CN(CCC2)C(C)=O)NC(C)=O)C2)=CC(CC)=CC=C1OC12CCC1 FOQIMCMQAHVRSZ-CCIHKAHMSA-N 0.000 claims 1
FOOVOKYFKXNBED-KKUQBAQOSA-N n-[(2s,3r)-1-(1-benzofuran-2-yl)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@@H](C1=CC(CC(C)(C)C)=CN=C1O1)NC[C@@H](O)[C@H](CC=2OC3=CC=CC=C3C=2)NC(=O)C)C21CCC2 FOOVOKYFKXNBED-KKUQBAQOSA-N 0.000 claims 1
CDDAJJUYPLMFFO-CCDWMCETSA-N n-[(2s,3r)-1-(2,6-difluorophenyl)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C1=C(F)C=CC=C1F CDDAJJUYPLMFFO-CCDWMCETSA-N 0.000 claims 1
BNXIACZNQPTSSD-KMDXXIMOSA-N n-[(2s,3r)-1-(2-chloro-6-methylpyridin-4-yl)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C1=CC(C)=NC(Cl)=C1 BNXIACZNQPTSSD-KMDXXIMOSA-N 0.000 claims 1
UAMUISNPBXPDJP-CCDWMCETSA-N n-[(2s,3r)-1-(2-chlorophenyl)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C1=CC=CC=C1Cl UAMUISNPBXPDJP-CCDWMCETSA-N 0.000 claims 1
RZVBZFXUKAEOIB-JIMJEQGWSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[(1r)-7-(2,2-dimethylpropyl)-3,3-dimethyl-4-oxo-1,2-dihydronaphthalen-1-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@H]1C2=CC(CC(C)(C)C)=CC=C2C(=O)C(C)(C)C1)C1=CC(F)=CC(F)=C1 RZVBZFXUKAEOIB-JIMJEQGWSA-N 0.000 claims 1
DMSRCGAVUVUKMW-FQJHJXCSSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[(2r,4r)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,3'-oxolane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@H]1C2=CC(CC(C)(C)C)=CN=C2O[C@]2(COCC2)C1)C1=CC(F)=CC(F)=C1 DMSRCGAVUVUKMW-FQJHJXCSSA-N 0.000 claims 1
DMSRCGAVUVUKMW-CDILPITASA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[(2r,4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,3'-oxolane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2O[C@]2(COCC2)C1)C1=CC(F)=CC(F)=C1 DMSRCGAVUVUKMW-CDILPITASA-N 0.000 claims 1
UDTZUCALHYIIIT-HPUZDQILSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[(2s,4s)-6-ethylspiro[3,4-dihydrochromene-2,3'-oxolane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)C2)=CC(CC)=CC=C1O[C@@]12CCOC1 UDTZUCALHYIIIT-HPUZDQILSA-N 0.000 claims 1
OMAIZYGPTREULJ-GMQQYTKMSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[(4s)-6-(2,2-dimethylpropyl)-8-propan-2-yloxyspiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@@H](C=1C=C(CC(C)(C)C)N=C(C=1O1)OC(C)C)NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)C21CCC2 OMAIZYGPTREULJ-GMQQYTKMSA-N 0.000 claims 1
NOZZVOJNQTZIPP-RJGXRXQPSA-N n-[(2s,3r)-1-(3,5-difluorophenyl)-4-[[(4s)-6-ethylspiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(F)C=C(F)C=2)NC(C)=O)C2)=CC(CC)=CN=C1OC12CCC1 NOZZVOJNQTZIPP-RJGXRXQPSA-N 0.000 claims 1
BQLRKQYKBHSHRU-CCDWMCETSA-N n-[(2s,3r)-1-(3-bromo-4-fluorophenyl)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C1=CC=C(F)C(Br)=C1 BQLRKQYKBHSHRU-CCDWMCETSA-N 0.000 claims 1
KAPLIPXREPVYPH-KMDXXIMOSA-N n-[(2s,3r)-1-(3-chloro-5-fluorophenyl)-3-hydroxy-4-[[(4s)-6-(2-hydroxy-2-methylpropyl)spiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]butan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)O)=NC=C2OC2(CCC2)C1)C1=CC(F)=CC(Cl)=C1 KAPLIPXREPVYPH-KMDXXIMOSA-N 0.000 claims 1
ZNHPLLVKRFJFLT-RBZQAINGSA-N n-[(2s,3r)-1-(3-cyanophenyl)-3-hydroxy-4-[[(1r)-7-methoxy-3,3-dimethyl-4-oxo-1,2-dihydronaphthalen-1-yl]amino]butan-2-yl]-2-methoxyacetamide Chemical compound C([C@H](NC(=O)COC)[C@H](O)CN[C@H]1C2=CC(OC)=CC=C2C(=O)C(C)(C)C1)C1=CC=CC(C#N)=C1 ZNHPLLVKRFJFLT-RBZQAINGSA-N 0.000 claims 1
NMJUOWGWEULNHY-RBZQAINGSA-N n-[(2s,3r)-1-(3-cyanophenyl)-3-hydroxy-4-[[(1r)-7-methoxy-3,3-dimethyl-4-oxo-1,2-dihydronaphthalen-1-yl]amino]butan-2-yl]acetamide Chemical compound C([C@@H]([C@H](O)CN[C@@H]1CC(C)(C)C(=O)C2=CC=C(C=C21)OC)NC(C)=O)C1=CC=CC(C#N)=C1 NMJUOWGWEULNHY-RBZQAINGSA-N 0.000 claims 1
WUSBKIIPHRACDX-KKUQBAQOSA-N n-[(2s,3r)-1-(3-cyanophenyl)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C1=CC=CC(C#N)=C1 WUSBKIIPHRACDX-KKUQBAQOSA-N 0.000 claims 1
GSSLCFLHVNRVIG-KKUQBAQOSA-N n-[(2s,3r)-1-(3-cyanophenyl)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(C=CC=2)C#N)NC(=O)CN2C(OCC2)=O)C2)=CC(CC)=CC=C1OC12CCC1 GSSLCFLHVNRVIG-KKUQBAQOSA-N 0.000 claims 1
BDUKFURARPTELL-CCDWMCETSA-N n-[(2s,3r)-1-(3-cyanophenyl)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]-2-methoxyacetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(C=CC=2)C#N)NC(=O)COC)C2)=CC(CC)=CC=C1OC12CCC1 BDUKFURARPTELL-CCDWMCETSA-N 0.000 claims 1
DRNVFBXXOGITRL-OIFRRMEBSA-N n-[(2s,3r)-1-(3-cyanophenyl)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]-2-phenoxyacetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(C=CC=2)C#N)NC(=O)COC=2C=CC=CC=2)C2)=CC(CC)=CC=C1OC12CCC1 DRNVFBXXOGITRL-OIFRRMEBSA-N 0.000 claims 1
XYLJFRJPLIJCKC-CCDWMCETSA-N n-[(2s,3r)-1-(3-cyanophenyl)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(C=CC=2)C#N)NC(C)=O)C2)=CC(CC)=CC=C1OC12CCC1 XYLJFRJPLIJCKC-CCDWMCETSA-N 0.000 claims 1
CZOPXKQMSNLYKH-CCDWMCETSA-N n-[(2s,3r)-1-(3-cyanophenyl)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]propanamide Chemical compound C([C@H](NC(=O)CC)[C@H](O)CN[C@@H]1C2=CC(CC)=CC=C2OC2(CCC2)C1)C1=CC=CC(C#N)=C1 CZOPXKQMSNLYKH-CCDWMCETSA-N 0.000 claims 1
IAPFLLDNGSEQJC-KMDXXIMOSA-N n-[(2s,3r)-1-(3-cyanophenyl)-4-[[(4s)-6-ethylspiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]-2-methoxyacetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(C=CC=2)C#N)NC(=O)COC)C2)=CC(CC)=CN=C1OC12CCC1 IAPFLLDNGSEQJC-KMDXXIMOSA-N 0.000 claims 1
OAXMWLBSWJPLPK-GGFLZPDSSA-N n-[(2s,3r)-1-(3-fluorophenyl)-3-hydroxy-4-[[(4s)-6-[(2s)-3,3,3-trifluoro-2-methylpropyl]spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]butan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(F)C=CC=2)NC(C)=O)C2)=CC(C[C@H](C)C(F)(F)F)=CN=C1OC12CCC1 OAXMWLBSWJPLPK-GGFLZPDSSA-N 0.000 claims 1
ZPZXFRAHZVMTJS-FQJHJXCSSA-N n-[(2s,3r)-1-(4-chlorophenyl)-4-[[(2r,4r)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,3'-oxolane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@H]1C2=CC(CC(C)(C)C)=CN=C2O[C@]2(COCC2)C1)C1=CC=C(Cl)C=C1 ZPZXFRAHZVMTJS-FQJHJXCSSA-N 0.000 claims 1
ZPZXFRAHZVMTJS-CDILPITASA-N n-[(2s,3r)-1-(4-chlorophenyl)-4-[[(2r,4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,3'-oxolane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2O[C@]2(COCC2)C1)C1=CC=C(Cl)C=C1 ZPZXFRAHZVMTJS-CDILPITASA-N 0.000 claims 1
WFLXNGWTEYYRAX-KKUQBAQOSA-N n-[(2s,3r)-1-(4-chlorophenyl)-4-[[(4s)-6-(2,2-dimethylbut-3-ynyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C#C)=CN=C2OC2(CCC2)C1)C1=CC=C(Cl)C=C1 WFLXNGWTEYYRAX-KKUQBAQOSA-N 0.000 claims 1
DYVCXXGYOURUSA-KKUQBAQOSA-N n-[(2s,3r)-1-(4-chlorophenyl)-4-[[(4s)-6-(2,2-dimethylbutyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC(Cl)=CC=2)NC(C)=O)C2)=CC(CC(C)(C)CC)=CN=C1OC12CCC1 DYVCXXGYOURUSA-KKUQBAQOSA-N 0.000 claims 1
ODDWWSJGPLLKFI-CXSMSNRLSA-N n-[(2s,3r)-1-(4-chlorophenyl)-4-[[(4s)-6-[(1s)-1-fluoro-2,2-dimethylpropyl]spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(=CN=C2OC2(CCC2)C1)[C@@H](F)C(C)(C)C)C1=CC=C(Cl)C=C1 ODDWWSJGPLLKFI-CXSMSNRLSA-N 0.000 claims 1
DAKKPMHNILAGSU-CCDWMCETSA-N n-[(2s,3r)-1-(4-fluoro-3-methylphenyl)-4-[[(4s)-6-(2-fluoro-2-methylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)F)=CN=C2OC2(CCC2)C1)C1=CC=C(F)C(C)=C1 DAKKPMHNILAGSU-CCDWMCETSA-N 0.000 claims 1
AMBXNGPAQJZTIH-CCDWMCETSA-N n-[(2s,3r)-1-(4-fluorophenyl)-3-hydroxy-4-[[(4s)-6-(2-methylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]butan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC(F)=CC=2)NC(C)=O)C2)=CC(CC(C)C)=CN=C1OC12CCC1 AMBXNGPAQJZTIH-CCDWMCETSA-N 0.000 claims 1
IGPZIUUUAOWIIW-KMDXXIMOSA-N n-[(2s,3r)-1-(4-fluorophenyl)-3-hydroxy-4-[[(4s)-6-propylspiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]butan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC(F)=CC=2)NC(C)=O)C2)=CC(CCC)=CN=C1OC12CCC1 IGPZIUUUAOWIIW-KMDXXIMOSA-N 0.000 claims 1
UTERZPGUGZHCAR-PCCBWWKXSA-N n-[(2s,3r)-3-hydroxy-1-phenyl-4-[[(4s)-2,6,6-trimethyl-5,7-dihydro-4h-1-benzofuran-4-yl]amino]butan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C=2C=C(C)OC=2CC(C)(C)C1)C1=CC=CC=C1 UTERZPGUGZHCAR-PCCBWWKXSA-N 0.000 claims 1
DWYZIQWQHNIECY-ISJGIBHGSA-N n-[(2s,3r)-3-hydroxy-4-[[(1r)-7-(2-methoxyethylamino)-3,3-dimethyl-4-oxo-1,2-dihydronaphthalen-1-yl]amino]-1-phenylbutan-2-yl]acetamide Chemical compound C([C@@H]([C@H](O)CN[C@@H]1CC(C)(C)C(=O)C2=CC=C(C=C21)NCCOC)NC(C)=O)C1=CC=CC=C1 DWYZIQWQHNIECY-ISJGIBHGSA-N 0.000 claims 1
GMHCBOGSXGMCIF-KKUQBAQOSA-N n-[(2s,3r)-3-hydroxy-4-[[(4s)-6-(3-methylbutyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-phenylbutan-2-yl]-2-methoxyacetamide Chemical compound C([C@H](NC(=O)COC)[C@H](O)CN[C@@H]1C2=CC(CCC(C)C)=CN=C2OC2(CCC2)C1)C1=CC=CC=C1 GMHCBOGSXGMCIF-KKUQBAQOSA-N 0.000 claims 1
OYXTXWNYHMNFEP-SSUZURRFSA-N n-[(2s,3r)-3-hydroxy-4-[[(4s)-6-[(2s)-oxolan-2-yl]spiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(=CC=C2OC2(CCC2)C1)[C@H]1OCCC1)C1=CC=CC=C1 OYXTXWNYHMNFEP-SSUZURRFSA-N 0.000 claims 1
UUQAXOVTDUHVNH-WDTRASESSA-N n-[(2s,3r)-3-hydroxy-4-[[(4s)-6-[[(2r)-2-methyloxolan-2-yl]methyl]spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(C[C@]3(C)OCCC3)=CN=C2OC2(CCC2)C1)C1=CC=CC=C1 UUQAXOVTDUHVNH-WDTRASESSA-N 0.000 claims 1
YNHWCLFEEDJTNJ-GYUKIKGESA-N n-[(2s,3r)-3-hydroxy-4-[[(4s)-6-[[(2r)-oxolan-2-yl]methyl]spiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(C[C@@H]3OCCC3)=CC=C2OC2(CCC2)C1)C1=CC=CC=C1 YNHWCLFEEDJTNJ-GYUKIKGESA-N 0.000 claims 1
AFNUOMRXRGRYLK-HMNRDNJPSA-N n-[(2s,3r)-3-hydroxy-4-[[(4s)-6-[[(2r)-oxolan-2-yl]methyl]spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(C[C@@H]3OCCC3)=CN=C2OC2(CCC2)C1)C1=CC=CC=C1 AFNUOMRXRGRYLK-HMNRDNJPSA-N 0.000 claims 1
KGBBCOHRANKVDH-ZCLKUGBOSA-N n-[(2s,3r)-3-hydroxy-4-[[(4s)-6-[[(2s)-oxolan-2-yl]methyl]spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-phenylbutan-2-yl]-2-methoxyacetamide Chemical compound C([C@H](NC(=O)COC)[C@H](O)CN[C@@H]1C2=CC(C[C@H]3OCCC3)=CN=C2OC2(CCC2)C1)C1=CC=CC=C1 KGBBCOHRANKVDH-ZCLKUGBOSA-N 0.000 claims 1
ZDOVUIOQKZPCLW-GMQQYTKMSA-N n-[(2s,3r)-4-[[(1s)-7-(cyclopentylamino)-3,3-dimethyl-4-oxo-1,2-dihydronaphthalen-1-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(NC3CCCC3)=CC=C2C(=O)C(C)(C)C1)C1=CC=CC=C1 ZDOVUIOQKZPCLW-GMQQYTKMSA-N 0.000 claims 1
YXXSUWYLMCDEAZ-XWZVPRMZSA-N n-[(2s,3r)-4-[[(2r,4s)-6-chloro-8-morpholin-4-ylspiro[3,4-dihydrochromene-2,3'-oxolane]-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=C(C(=CC(Cl)=C2)N2CCOCC2)O[C@]2(COCC2)C1)C1=CC(F)=CC(F)=C1 YXXSUWYLMCDEAZ-XWZVPRMZSA-N 0.000 claims 1
BIHRVTGDRMCRBV-QXUYBEEESA-N n-[(2s,3r)-4-[[(2r,4s)-6-chlorospiro[3,4-dihydropyrano[2,3-b]pyridine-2,3'-oxolane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(Cl)=CN=C2O[C@]2(COCC2)C1)C1=CC=CC=C1 BIHRVTGDRMCRBV-QXUYBEEESA-N 0.000 claims 1
LTKKNMVAMBUECM-NAVOWQOKSA-N n-[(2s,3r)-4-[[(2s,4s)-1'-acetyl-6-ethylspiro[3,4-dihydrochromene-2,3'-pyrrolidine]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(C)=O)C2)=CC(CC)=CC=C1O[C@]12CCN(C(C)=O)C1 LTKKNMVAMBUECM-NAVOWQOKSA-N 0.000 claims 1
OAPVYUJRXSHJFV-RGYUWNBKSA-N n-[(2s,3r)-4-[[(2s,4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,3'-oxolane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-methoxyacetamide Chemical compound C([C@H](NC(=O)COC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2O[C@@]2(COCC2)C1)C1=CC=CC=C1 OAPVYUJRXSHJFV-RGYUWNBKSA-N 0.000 claims 1
RPLRVPIJGAVSFX-KEZQHZCBSA-N n-[(2s,3r)-4-[[(2s,4s)-6-bromo-2-methyl-2-(trifluoromethyl)-3,4-dihydrochromen-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(Br)=CC=C2O[C@@](C)(C1)C(F)(F)F)C1=CC=CC=C1 RPLRVPIJGAVSFX-KEZQHZCBSA-N 0.000 claims 1
CLMFBRCNMBGVJX-OYUWMTPXSA-N n-[(2s,3r)-4-[[(4r)-6-(2,2-dimethylpropyl)-8-propan-2-yloxyspiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](C=1C=C(CC(C)(C)C)N=C(C=1O1)OC(C)C)NC[C@@H](O)[C@H](CC=2C=CC(F)=CC=2)NC(C)=O)C21CCC2 CLMFBRCNMBGVJX-OYUWMTPXSA-N 0.000 claims 1
WEFKDLDYYSHQRC-JBRSBNLGSA-N n-[(2s,3r)-4-[[(4r)-8-(dimethylamino)-6-ethyl-2,2-dimethyl-3,4-dihydrochromen-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@@H]([C@H](O)CN[C@H]1C=2C=C(C=C(C=2OC(C)(C)C1)N(C)C)CC)NC(C)=O)C1=CC=CC=C1 WEFKDLDYYSHQRC-JBRSBNLGSA-N 0.000 claims 1
RJEWKGNHSJODHQ-WPFOTENUSA-N n-[(2s,3r)-4-[[(4s)-1-acetyl-6-bromo-2,2-dimethyl-3,4-dihydroquinolin-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(Br)=CC=C2N(C(C)=O)C(C)(C)C1)C1=CC=CC=C1 RJEWKGNHSJODHQ-WPFOTENUSA-N 0.000 claims 1
OUCWEAFTVAXJCV-KMDXXIMOSA-N n-[(2s,3r)-4-[[(4s)-2-ethyl-6,6-dimethyl-5,7-dihydro-4h-1-benzothiophen-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(2-oxopyrrolidin-1-yl)acetamide Chemical compound C([C@@H]([C@H](O)CN[C@@H]1C=2C=C(SC=2CC(C)(C)C1)CC)NC(=O)CN1C(CCC1)=O)C1=CC=CC=C1 OUCWEAFTVAXJCV-KMDXXIMOSA-N 0.000 claims 1
ZQWWGBZQRZMGBQ-KKUQBAQOSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)-2,2-dimethyl-3,4-dihydro-1h-quinolin-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CC=C2NC(C)(C)C1)C1=CC=CC=C1 ZQWWGBZQRZMGBQ-KKUQBAQOSA-N 0.000 claims 1
XYYAANNCGMZRRC-KMDXXIMOSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)-2,2-dimethyl-3,4-dihydropyrano[2,3-b]pyridin-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC(C)(C)C1)C1=CC=C(F)C=C1 XYYAANNCGMZRRC-KMDXXIMOSA-N 0.000 claims 1
JJKXIZRLMNHXMH-KMDXXIMOSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)-2,2-dimethyl-3,4-dihydropyrano[2,3-c]pyridin-4-yl]amino]-1-(3-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=NC=C2OC(C)(C)C1)C1=CC=CC(F)=C1 JJKXIZRLMNHXMH-KMDXXIMOSA-N 0.000 claims 1
HPDATYCGMJPNRR-CCDWMCETSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)-8-methoxyspiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(3-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@@H](C=1C=C(CC(C)(C)C)N=C(C=1O1)OC)NC[C@@H](O)[C@H](CC=2C=C(F)C=CC=2)NC(C)=O)C21CCC2 HPDATYCGMJPNRR-CCDWMCETSA-N 0.000 claims 1
CRMCZCFMTGEBJC-HZFUHODCSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)-8-morpholin-4-ylspiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=C(C(=NC(CC(C)(C)C)=C2)N2CCOCC2)OC2(CCC2)C1)C1=CC=CC=C1 CRMCZCFMTGEBJC-HZFUHODCSA-N 0.000 claims 1
ZTDPMDMKRAIUPD-GMQQYTKMSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)-8-propan-2-yloxyspiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(3-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@@H](C=1C=C(CC(C)(C)C)N=C(C=1O1)OC(C)C)NC[C@@H](O)[C@H](CC=2C=C(F)C=CC=2)NC(C)=O)C21CCC2 ZTDPMDMKRAIUPD-GMQQYTKMSA-N 0.000 claims 1
CLMFBRCNMBGVJX-GMQQYTKMSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)-8-propan-2-yloxyspiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@@H](C=1C=C(CC(C)(C)C)N=C(C=1O1)OC(C)C)NC[C@@H](O)[C@H](CC=2C=CC(F)=CC=2)NC(C)=O)C21CCC2 CLMFBRCNMBGVJX-GMQQYTKMSA-N 0.000 claims 1
ZAJKCLUZHUAIIX-CCDWMCETSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(2-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C1=CC=CC=C1F ZAJKCLUZHUAIIX-CCDWMCETSA-N 0.000 claims 1
FGETYKYHLUCWPV-RJGXRXQPSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]-2,2-difluoroacetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC(F)=CC=2)NC(=O)C(F)F)C2)=CC(CC(C)(C)C)=CN=C1OC12CCC1 FGETYKYHLUCWPV-RJGXRXQPSA-N 0.000 claims 1
FYUUNYNZWADHLV-CCDWMCETSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(trifluoromethyl)phenyl]butan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C1=CC=CC(C(F)(F)F)=C1 FYUUNYNZWADHLV-CCDWMCETSA-N 0.000 claims 1
FKUSUFVBJLHBPS-HZFUHODCSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(5-methylpyrazol-1-yl)acetamide Chemical compound CC1=CC=NN1CC(=O)N[C@H]([C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)CC1=CC=CC=C1 FKUSUFVBJLHBPS-HZFUHODCSA-N 0.000 claims 1
CMQTXZOXZRICDX-CCDWMCETSA-N n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=NC=C2OC2(CCC2)C1)C1=CC=CC=C1 CMQTXZOXZRICDX-CCDWMCETSA-N 0.000 claims 1
XEFTVFYBIIOHLH-KMDXXIMOSA-N n-[(2s,3r)-4-[[(4s)-6-(2-fluoro-2-methylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)F)=CN=C2OC2(CCC2)C1)C1=CC=CC=C1 XEFTVFYBIIOHLH-KMDXXIMOSA-N 0.000 claims 1
RVHAZHOLYWGIHZ-CXSMSNRLSA-N n-[(2s,3r)-4-[[(4s)-6-[(1r)-1-fluoro-2-methylpropyl]spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC(F)=CC=2)NC(C)=O)C2)=CC([C@H](F)C(C)C)=CN=C1OC12CCC1 RVHAZHOLYWGIHZ-CXSMSNRLSA-N 0.000 claims 1
NSFNRHDXSOQIKI-CXSMSNRLSA-N n-[(2s,3r)-4-[[(4s)-6-[(1s)-1-fluoro-2,2-dimethylpropyl]spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(=CN=C2OC2(CCC2)C1)[C@@H](F)C(C)(C)C)C1=CC=C(F)C=C1 NSFNRHDXSOQIKI-CXSMSNRLSA-N 0.000 claims 1
HCSAUHXMCQXWJH-XLRUWRGTSA-N n-[(2s,3r)-4-[[(4s)-6-[(2r)-3-fluoro-2-methylpropyl]spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC(F)=CC=2)NC(C)=O)C2)=CC(C[C@H](CF)C)=CN=C1OC12CCC1 HCSAUHXMCQXWJH-XLRUWRGTSA-N 0.000 claims 1
BNKKNNRDNAMWKW-FDFHNCONSA-N n-[(2s,3r)-4-[[(4s)-6-bromo-2,2-dimethyl-3,4-dihydro-1h-quinolin-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(Br)=CC=C2NC(C)(C)C1)C1=CC=CC=C1 BNKKNNRDNAMWKW-FDFHNCONSA-N 0.000 claims 1
UYIYYVXNBPPUFP-FDFHNCONSA-N n-[(2s,3r)-4-[[(4s)-6-bromospiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-1-(3,5-difluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(Br)=CC=C2OC2(CCC2)C1)C1=CC(F)=CC(F)=C1 UYIYYVXNBPPUFP-FDFHNCONSA-N 0.000 claims 1
YDIVXCZMBDZKOK-PCCBWWKXSA-N n-[(2s,3r)-4-[[(4s)-6-bromospiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(Br)=CN=C2OC2(CCC2)C1)C1=CC=C(F)C=C1 YDIVXCZMBDZKOK-PCCBWWKXSA-N 0.000 claims 1
PUWMOTSQDRSSHT-OHSXHVKISA-N n-[(2s,3r)-4-[[(4s)-6-chloro-8-morpholin-4-ylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-1-(3-cyanophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=C(C(=CC(Cl)=C2)N2CCOCC2)OC2(CCC2)C1)C1=CC=CC(C#N)=C1 PUWMOTSQDRSSHT-OHSXHVKISA-N 0.000 claims 1
XCDLZZNRQMUGRN-OHSXHVKISA-N n-[(2s,3r)-4-[[(4s)-6-ethyl-2,2-dimethyl-8-pyrrolidin-1-yl-3,4-dihydrochromen-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]acetamide Chemical compound C([C@@H](C=1C=C(C=2)CC)NC[C@@H](O)[C@H](CC=3C=CC=CC=3)NC(C)=O)C(C)(C)OC=1C=2N1CCCC1 XCDLZZNRQMUGRN-OHSXHVKISA-N 0.000 claims 1
KNUQXNGMAGESQG-RWSKJCERSA-N n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-(3-prop-2-enylphenyl)butan-2-yl]hept-6-enamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=C(CC=C)C=CC=2)NC(=O)CCCCC=C)C2)=CC(CC)=CC=C1OC12CCC1 KNUQXNGMAGESQG-RWSKJCERSA-N 0.000 claims 1
FZRDGNVMKBNQIT-CCDWMCETSA-N n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)CN2C(OCC2)=O)C2)=CC(CC)=CC=C1OC12CCC1 FZRDGNVMKBNQIT-CCDWMCETSA-N 0.000 claims 1
BZDINFCSPPULSF-OIFRRMEBSA-N n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(3-oxo-1h-isoindol-2-yl)acetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)CN2C(C3=CC=CC=C3C2)=O)C2)=CC(CC)=CC=C1OC12CCC1 BZDINFCSPPULSF-OIFRRMEBSA-N 0.000 claims 1
WOWRZGXTDDGJCI-HZFUHODCSA-N n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-(4-propyltriazol-1-yl)acetamide Chemical compound N1=NC(CCC)=CN1CC(=O)N[C@H]([C@H](O)CN[C@@H]1C2=CC(CC)=CC=C2OC2(CCC2)C1)CC1=CC=CC=C1 WOWRZGXTDDGJCI-HZFUHODCSA-N 0.000 claims 1
YHACHHURHPYYGI-OIFRRMEBSA-N n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-phthalazin-1-ylsulfanylacetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)CSC=2C3=CC=CC=C3C=NN=2)C2)=CC(CC)=CC=C1OC12CCC1 YHACHHURHPYYGI-OIFRRMEBSA-N 0.000 claims 1
IMIVZZHWYHXNBD-YTCPBCGMSA-N n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-pyrrolo[2,3-b]pyridin-1-ylacetamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)CN2C3=NC=CC=C3C=C2)C2)=CC(CC)=CC=C1OC12CCC1 IMIVZZHWYHXNBD-YTCPBCGMSA-N 0.000 claims 1
IWLFPJWTXSHWFV-SSNGLDLMSA-N n-[(2s,3r)-4-[[(4s)-6-ethylspiro[3,4-dihydrochromene-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-phenylbutan-2-yl]-2-thiophen-2-ylsulfanylpropanamide Chemical compound C1([C@@H](NC[C@@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)C(C)SC=2SC=CC=2)C2)=CC(CC)=CC=C1OC12CCC1 IWLFPJWTXSHWFV-SSNGLDLMSA-N 0.000 claims 1
NOXDMGCXAAVHAI-HZFUHODCSA-N n-[(2s,3r)-4-[[(4s)-8-(dimethylamino)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-[4-(dimethylamino)phenyl]-3-hydroxybutan-2-yl]acetamide Chemical compound C1=CC(N(C)C)=CC=C1C[C@H](NC(C)=O)[C@H](O)CN[C@@H]1C(C=C(CC(C)(C)C)N=C2N(C)C)=C2OC2(CCC2)C1 NOXDMGCXAAVHAI-HZFUHODCSA-N 0.000 claims 1
FCTGWYSVAGSHCI-KMDXXIMOSA-N n-[(2s,3r)-4-[[(4s)-8-chloro-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(3-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=NC(Cl)=C2OC2(CCC2)C1)C1=CC=CC(F)=C1 FCTGWYSVAGSHCI-KMDXXIMOSA-N 0.000 claims 1
RDNVORBKZVZOMD-KMDXXIMOSA-N n-[(2s,3r)-4-[[(4s)-8-chloro-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-c]pyridine-2,1'-cyclobutane]-4-yl]amino]-1-(4-fluorophenyl)-3-hydroxybutan-2-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=NC(Cl)=C2OC2(CCC2)C1)C1=CC=C(F)C=C1 RDNVORBKZVZOMD-KMDXXIMOSA-N 0.000 claims 1
HQOAUESNWDRKPT-KMDXXIMOSA-N n-[(4s)-4-[[(2r,3s)-3-acetamido-4-(3,5-difluorophenyl)-2-hydroxybutyl]amino]spiro[3,4-dihydrochromene-2,1'-cyclobutane]-6-yl]acetamide Chemical compound C([C@H](NC(=O)C)[C@H](O)CN[C@@H]1C2=CC(NC(C)=O)=CC=C2OC2(CCC2)C1)C1=CC(F)=CC(F)=C1 HQOAUESNWDRKPT-KMDXXIMOSA-N 0.000 claims 1
125000004433 nitrogen atom Chemical group N* 0.000 claims 1
KNEPBZMJMJUNQX-UHFFFAOYSA-N pent-4-ynamide Chemical compound NC(=O)CCC#C KNEPBZMJMJUNQX-UHFFFAOYSA-N 0.000 claims 1
229940080818 propionamide Drugs 0.000 claims 1
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
201000010099 disease Diseases 0.000 abstract 2
239000000543 intermediate Substances 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Quinoline Compounds (AREA)
Furan Compounds (AREA)
Pyrane Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

CA2629402A 2005-11-21 2006-11-13 Modulateurs de beta-secretase et procedes d'utilisation associes Expired - Fee Related CA2629402C (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US73910805P	2005-11-21	2005-11-21
US60/739,108		2005-11-21
US85482406P	2006-10-27	2006-10-27
US60/854,824		2006-10-27
PCT/US2006/044058 WO2007061670A1 (fr)	2005-11-21	2006-11-13	Modulateurs de beta-secretase et procedes d'utilisation associes

Publications (2)

Publication Number	Publication Date
CA2629402A1 true CA2629402A1 (fr)	2007-05-31
CA2629402C CA2629402C (fr)	2011-07-26

Family

ID=39708735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2629402A Expired - Fee Related CA2629402C (fr)	2005-11-21	2006-11-13	Modulateurs de beta-secretase et procedes d'utilisation associes

Country Status (8)

Country	Link
EP (1)	EP1971598A1 (fr)
JP (1)	JP5274258B2 (fr)
AR (1)	AR057985A1 (fr)
AU (1)	AU2006316620B2 (fr)
CA (1)	CA2629402C (fr)
PE (1)	PE20070645A1 (fr)
TW (1)	TW200800966A (fr)
WO (1)	WO2007061670A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7763609B2 (en)	2003-12-15	2010-07-27	Schering Corporation	Heterocyclic aspartyl protease inhibitors
JP5440984B2 (ja) *	2007-05-25	2014-03-12	アムジエン・インコーポレーテツド	β−セクレターゼ修飾剤としての置換ヒドロキシエチルアミン化合物および使用方法
US8163909B2 (en) *	2007-05-25	2012-04-24	Amgen Inc.	Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
DK2734494T3 (en)	2011-07-21	2019-02-25	Ge Healthcare Ltd	PRECURSOR RELATIONS AND PROCEDURES FOR PREPARING THE SAME
EP2827857A4 (fr) *	2012-03-20	2016-03-30	Elan Pharm Inc	Dihydro-thiazine spirocycliques et inhibiteurs de bace dihydro-oxazine et compositions et utilisations de ceux-ci
US9932333B2 (en)	2014-07-16	2018-04-03	Japan Science And Technology Agency	Benzothiazole compound and medicine containing same
CN113543852A (zh)	2019-03-06	2021-10-22	第一三共株式会社	吡咯并吡唑衍生物

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY138097A (en)	2000-03-22	2009-04-30	Du Pont	Insecticidal anthranilamides
ES2252257T3 (es)	2000-06-30	2006-05-16	Elan Pharmaceuticals, Inc.	Compuestos para tratar la enfermedad de alzheimer.
US7196163B2 (en)	2001-05-22	2007-03-27	Merk & Co., Inc.	Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity
CA2452039A1 (fr)	2001-06-27	2003-01-09	Elan Pharmaceuticals, Inc.	Derives de beta-hydroxyamine utiles dans le traitement de la maladie d'alzheimer
KR100713137B1 (ko)	2001-06-28	2007-05-02	동화약품공업주식회사	신규의 2,4-디플루오로벤즈아미드 유도체
WO2003006013A1 (fr)	2001-07-10	2003-01-23	Elan Pharmaceuticals, Inc.	Diaminediols pour le traitement de la maladie d'alzheimer
EP1404328A1 (fr)	2001-07-10	2004-04-07	Elan Pharmaceuticals, Inc.	Derives de statine alpha-hydroxyamide pour le traitement de la maladie d'alzheimer
HRP20040069A2 (en)	2001-07-11	2005-02-28	Elan Pharmaceuticals Pharmacia & Upjohn Company	N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
CA2462851A1 (fr)	2001-10-04	2003-04-10	Elan Pharmaceuticals, Inc.	Hydroxypropylamines
US20050027007A1 (en)	2001-10-05	2005-02-03	Roy Hom	Allylamides useful in the treatment of alzheimer's disease
CA2465316A1 (fr)	2001-10-29	2003-05-08	James P. Beck	Amides a substitution hydroxy pour le traitement de la maladie d'alzheimer
AR039555A1 (es)	2001-11-08	2005-02-23	Upjohn Co	Derivados n,n'-sustituidos de 1,3-diamino-2-hidroxipropano
AR037460A1 (es)	2001-11-30	2004-11-10	Smithkline Beecham Plc	Compuesto de hidroxietileno, composicion farmaceutica que lo comprende, uso del mismo para la fabricacion de un medicamento y procedimiento para su preparacion
CA2469622A1 (fr)	2001-12-06	2003-06-19	Elan Pharmaceuticals, Inc.	Hydroxyethylamines substitues
CA2472617A1 (fr)	2002-01-04	2003-07-17	Elan Pharmaceuticals, Inc.	Amino carboxamides substitues destines au traitement de la maladie d'alzheimer
CA2473796A1 (fr)	2002-01-17	2003-07-31	Neurogen Corporation	Analogues de quinazoline-4-ylamine substitues
EP1515944A1 (fr)	2002-06-17	2005-03-23	Sunesis Pharmaceuticals, Inc.	Inhibiteurs de l'aspartyl-protease
CN1324017C (zh)	2002-06-20	2007-07-04	法玛西和厄普约翰有限责任公司	5－(1,3－噁唑－2－基)苯甲酸衍生物的制备方法
UY27967A1 (es) *	2002-09-10	2004-05-31	Pfizer	Acetil 2-hindroxi-1,3-diaminoalcanos
US7362070B2 (en)	2002-11-04	2008-04-22	Hamilton Sundstrand Corporation	Electric motor control system including position determination and error correction
ATE443043T1 (de)	2002-11-12	2009-10-15	Merck & Co Inc	Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
BR0316629A (pt) *	2002-11-27	2005-10-11	Elan Pharm Inc	Uréias e carbamatos substituìdos
GB0228410D0 (en)	2002-12-05	2003-01-08	Glaxo Group Ltd	Novel Compounds
EP1583750B1 (fr)	2003-01-07	2013-02-27	Merck Sharp & Dohme Corp.	Inhibiteurs de bêta-sécrétase macrocyclique pour traiter la maladie d'Alzheimer
GB0305918D0 (en)	2003-03-14	2003-04-23	Glaxo Group Ltd	Novel compounds
RU2005131845A (ru)	2003-03-14	2006-02-10	Мерк Шарп энд Домэ Лимитед (GB)	Способ лечения легкого ухудшения познавательной способности и предотвращения или задержки начала болезни альцгеймера
PE20050420A1 (es) *	2003-04-21	2005-06-13	Elan Pharm Inc	Fenacilo 2-hidroxi-3-diaminoalcanos
TW200512195A (en)	2003-04-21	2005-04-01	Elan Pharm Inc	Benzamide 2-hydroxy-3-diaminoalkanes
GB0309221D0 (en) *	2003-04-23	2003-06-04	Glaxo Group Ltd	Novel compounds
EP1644322A1 (fr)	2003-06-16	2006-04-12	Sunesis Pharmaceuticals, Inc.	Inhibiteurs d'aspartyl-protease
CN100430377C (zh)	2003-06-30	2008-11-05	麦克公司	用于治疗阿尔茨海默病的N-烷基苯基甲酰胺β分泌酶抑制剂
AU2004255191A1 (en)	2003-07-01	2005-01-20	Merck & Co., Inc.	Phenylcarboxylate beta-secretase inhibitors for the treatment of Alzheimer's disease
GB0317491D0 (en) *	2003-07-25	2003-08-27	Novartis Ag	Organic compounds
JP2007522129A (ja) *	2004-01-21	2007-08-09	エランファーマシューティカルズ，インコーポレイテッド	アスパラギン酸プロテアーゼ阻害薬を用いるアミロイドーシスの処置方法
US20050239832A1 (en) *	2004-03-09	2005-10-27	Varghese John	Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
US7544717B2 (en) *	2004-03-25	2009-06-09	Elan Pharmaceuticals, Inc.	2-amino- and 2-thio- substituted 1,3-diaminopropanes

2006
- 2006-11-13 EP EP06837478A patent/EP1971598A1/fr not_active Withdrawn
- 2006-11-13 AU AU2006316620A patent/AU2006316620B2/en not_active Ceased
- 2006-11-13 WO PCT/US2006/044058 patent/WO2007061670A1/fr not_active Ceased
- 2006-11-13 CA CA2629402A patent/CA2629402C/fr not_active Expired - Fee Related
- 2006-11-13 JP JP2008541258A patent/JP5274258B2/ja not_active Expired - Fee Related
- 2006-11-20 PE PE2006001476A patent/PE20070645A1/es not_active Application Discontinuation
- 2006-11-21 TW TW095143035A patent/TW200800966A/zh unknown
- 2006-11-21 AR ARP060105083A patent/AR057985A1/es unknown

Also Published As

Publication number	Publication date
AU2006316620A1 (en)	2007-05-31
AU2006316620B2 (en)	2011-03-03
EP1971598A1 (fr)	2008-09-24
TW200800966A (en)	2008-01-01
JP2009516684A (ja)	2009-04-23
PE20070645A1 (es)	2007-08-24
CA2629402C (fr)	2011-07-26
WO2007061670A1 (fr)	2007-05-31
JP5274258B2 (ja)	2013-08-28
AR057985A1 (es)	2008-01-09

Publication	Publication Date	Title
IL310992A (en)	2024-04-01	NLRP3 inhibitors
AU2023203292B2 (en)	2025-01-30	Bicyclic ketone compounds and methods of use thereof
CA3236104A1 (fr)	2023-05-04	Derives de piperidinyl indole, leurs procedes de preparation et leurs utilisations medicales
WO2018073193A1 (fr)	2018-04-26	Lactames de pyridone bicycliques et leurs méthodes d'utilisation
US10214537B2 (en)	2019-02-26	Bicyclic heteroaryl amine compounds
EA030376B1 (ru)	2018-07-31	Азетидиновые производные пиперидин-4-ила как ингибиторы jak1
CA2629466A1 (fr)	2007-05-31	Modulateurs de la beta-secretase et procedes d'utilisation de ceux-ci
EP3548484A1 (fr)	2019-10-09	Composés amide bicycliques et leurs procédés d'utilisation
CA2629402A1 (fr)	2007-05-31	Modulateurs de beta-secretase et procedes d'utilisation associes
KR102839382B1 (ko)	2025-07-25	치환된 인돌 및 인다졸 화합물
JP7362600B2 (ja)	2023-10-17	Ｒｉｐ１キナーゼ阻害剤として使用するための二環式化合物
AU2020268933A1 (en)	2021-12-09	Bisheterocyclic carbonyl substituted dihydropyrazole compound, preparation method therefor and pharmaceutical use thereof
EA034904B1 (ru)	2020-04-03	Производные 3-(карбоксиметил)-8-амино-2-оксо-1,3-диазаспиро-[4.5]-декана
CA2629462A1 (fr)	2007-05-31	Modulateurs de beta-secretase et procedes d'utilisation
IL291958A (en)	2022-06-01	1,2,4-oxadiazole derivatives as liver x receptor agonists
US9034866B2 (en)	2015-05-19	Tricyclic compounds and methods of use therefor
JPWO2022073969A5 (fr)	2024-10-16
AU2022379477A1 (en)	2024-05-02	Spirotricycle ripk1 inhibitors and methods of uses thereof
US20210340151A1 (en)	2021-11-04	Bicyclic ketone compounds and methods of use thereof
RU2809869C1 (ru)	2023-12-19	Соединение на основе дигидронафтиридинона, и способ его получения, и его применение в медицине
AU2024221120A1 (en)	2025-09-25	Imidazotriazine il-17a modulators and uses thereof
RU2797922C2 (ru)	2023-06-13	Бициклические кетоны и способы их применения
WO2025147609A1 (fr)	2025-07-10	Composés aminoquinoléines et leurs utilisations
AU2024209890A1 (en)	2025-08-07	Novel alpk1 inhibitors
JP2024542974A (ja)	2024-11-19	Ｋｅａｐ１結合剤であるテトラヒドロイソキノリン化合物

Legal Events

Date	Code	Title	Description
2008-05-12	EEER	Examination request
2015-12-26	MKLA	Lapsed	Effective date: 20151113